WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2002000260) REMEDIAL AGENT FOR OPTIC NERVE DISEASE AND THE LIKE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/000260    International Application No.:    PCT/JP2001/005585
Publication Date: 03.01.2002 International Filing Date: 28.06.2001
Chapter 2 Demand Filed:    28.06.2001    
IPC:
A61K 31/00 (2006.01), A61K 31/4152 (2006.01)
Applicants: MITSUBISHI PHARMA CORPORATION [JP/JP]; 6-9, Hiranomachi 2-chome, Chuo-ku Osaka-shi, Osaka 541-0046 (JP) (For All Designated States Except US).
MANO, Tomiya [JP/JP]; (JP) (For US Only).
SOGOU, Shunji [JP/JP]; (JP) (For US Only).
INOUE, Eri [JP/JP]; (JP) (For US Only)
Inventors: MANO, Tomiya; (JP).
SOGOU, Shunji; (JP).
INOUE, Eri; (JP)
Agent: TAKAYANAGI, Masau; c/o MITSUBISHI PHARMA CORPORATION, Intellectual Property Department 2-6, Nihonbashi-honcho 2-chome Chuo-ku, Tokyo 103-8405 (JP)
Priority Data:
2000-197250 29.06.2000 JP
Title (EN) REMEDIAL AGENT FOR OPTIC NERVE DISEASE AND THE LIKE
(FR) JP0105585ATIF CONTRE DES MALADIES DU NERF OPTIQUE ET ANALOGUE
Abstract: front page image
(EN)A remedy and/or preventive for optic nerve diseases and the like which is effective in inhibiting retinal degeneration in transient retinal ischemia and hence functions to inhibit the retinal degeneration caused by transient retinal ischemia. It is therefore effective in treating and/or preventing optic nerve diseases and the like.
(FR)L'invention a trait à un remède et/ou un agent préventif contre des maladies du nerf optique et analogue, lequel est efficace pour inhiber une dégénérescence rétinienne dans l'ischémie rétinienne transitoire et par conséquent a pour fonction d'inhiber la dégénérescence rétinienne provoquée par une ischémie rétinienne transitoire. Par conséquent, il est efficace dans le traitement et/ou la prévention de maladies du nerf optique et analogue.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)